Pinnacle Associates LTD Abb Vie Inc. Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Pinnacle Associates LTD holds 123,638 shares of ABBV stock, worth $22.3 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

123,638

Previous 118,003 4.78%

Holding current value

$22.3 Million

Previous $20.2 Million 20.64%

% of portfolio

0.39%

Previous 0.33%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$163.84 - $199.33 $923,238 - $1.12 Million	5,635 Added 4.78%	123,638 $24.4 Million
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $121,664 - $142,077	-786 Reduced 0.66%	118,003 $20.2 Million
Q1 2024 Apr 26, 2024	SELL	$159.82 - $182.1 $774,967 - $883,002	-4,849 Reduced 3.92%	118,789 $21.6 Million
Q4 2023 Jan 19, 2024	SELL	$137.6 - $154.97 $33,849 - $38,122	-246 Reduced 0.2%	123,638 $19.2 Million
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $94,982 - $109,956	-711 Reduced 0.57%	123,884 $18.5 Million
Q2 2023 Jul 26, 2023	BUY	$132.51 - $164.9 $8.93 Million - $11.1 Million	67,370 Added 117.73%	124,595 $16.8 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $87,199 - $100,423	-603 Reduced 1.04%	57,225 $9.12 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $40,109 - $48,102	290 Added 0.5%	57,828 $9.35 Million
Q4 2022 Jan 25, 2023	SELL	$138.31 - $165.87 $219,912 - $263,733	-1,590 Reduced 2.69%	57,538 $0
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $134,210 - $153,930	1,000 Added 1.72%	59,128 $7.94 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $221,155 - $281,160	-1,607 Reduced 2.69%	58,128 $8.9 Million
Q1 2022 May 05, 2022	BUY	$131.98 - $163.75 $366,904 - $455,225	2,780 Added 4.88%	59,735 $9.68 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $223,024 - $282,190	2,076 Added 3.78%	56,955 $7.71 Million
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $268,234 - $304,486	2,521 Added 4.81%	54,879 $5.92 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $337,092 - $375,540	3,204 Added 6.52%	52,358 $5.9 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $25,575 - $28,155	-250 Reduced 0.51%	49,154 $5.32 Million
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $144,882 - $195,606	1,800 Added 3.78%	49,404 $5.29 Million
Q3 2020 Oct 23, 2020	BUY	$85.91 - $100.83 $133,246 - $156,387	1,551 Added 3.37%	47,604 $4.17 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $326,496 - $436,901	4,450 Added 10.7%	46,053 $4.52 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $281,284 - $426,462	4,361 Added 11.71%	41,603 $3.17 Million
Q4 2019 Feb 03, 2020	SELL	$72.13 - $90.25 $460,189 - $575,795	-6,380 Reduced 14.63%	37,242 $3.3 Million
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $437,459 - $525,951	-6,946 Reduced 13.74%	43,622 $3.3 Million
Q2 2019 Aug 05, 2019	SELL	$65.7 - $83.98 $3.89 Million - $4.97 Million	-59,224 Reduced 53.94%	50,568 $3.68 Million
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $1.32 Million - $1.55 Million	-17,057 Reduced 13.45%	109,792 $8.85 Million
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $1.07 Million - $1.32 Million	-13,716 Reduced 9.76%	126,849 $11.7 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $1.22 Million - $1.36 Million	-13,751 Reduced 8.91%	140,565 $13.3 Million
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $307,945 - $364,368	-3,430 Reduced 2.17%	154,316 $14.3 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $237,477 - $318,005	2,581 Added 1.66%	157,746 $14.9 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $747,019 - $819,169	-8,341 Reduced 5.1%	155,165 $15 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $30,454 - $38,899	-436 Reduced 0.27%	163,506 $14.5 Million
Q2 2017 Aug 09, 2017	BUY	N/A	163,942	163,942 $11.9 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Abb Vie Inc. Transaction History